<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Infectious disease surveillance needs for the United States: lessons from COVID-19 - Health AI Hub</title>
    <meta name="description" content="This paper leverages lessons from the COVID-19 pandemic in the U.S. and other jurisdictions to define the essential requirements for an effective infectious dis">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Infectious disease surveillance needs for the United States: lessons from COVID-19</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2311.13724v1" target="_blank">2311.13724v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2023-11-22
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Marc Lipsitch, Mary T. Bassett, John S. Brownstein, Paul Elliott, David Eyre, M. Kate Grabowski, James A. Hay, Michael Johansson, Stephen M. Kissler, Daniel B. Larremore, Jennifer Layden, Justin Lessler, Ruth Lynfield, Duncan MacCannell, Lawrence C. Madoff, C. Jessica E. Metcalf, Lauren A. Meyers, Sylvia K. Ofori, Celia Quinn, Ana I. Ramos Bento, Nick Reich, Steven Riley, Roni Rosenfeld, Matthew H. Samore, Rangarajan Sampath, Rachel B. Slayton, David L. Swerdlow, Shaun Truelove, Jay K. Varma, Yonatan H. Grad
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CY, physics.soc-ph, q-bio.PE
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2311.13724v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2311.13724v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper leverages lessons from the COVID-19 pandemic in the U.S. and other jurisdictions to define the essential requirements for an effective infectious disease surveillance and forecasting system. It details the specific data elements necessary to inform evidence-based public health decision-making, calibrate transmission-dynamic models, and support various levels of health authorities, ultimately aiming to enhance health equity.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for fortifying national public health infrastructure, enabling more rapid and effective responses to future infectious disease outbreaks, and ensuring that public health interventions are informed by robust data to achieve equitable health outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper implies the need for advanced computational methods, which often include AI/ML, for building effective surveillance systems, forecasting and modeling disease spread, analyzing complex surveillance data to inform public health decisions, and developing early warning systems for outbreaks. AI could be used for pattern recognition in diverse data types, predictive analytics for resource allocation, and optimizing public health interventions during pandemics.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>The COVID-19 pandemic exposed significant deficiencies in U.S. infectious disease surveillance, forecasting, and modeling capabilities.</li>
                    
                    <li>The paper delineates specific requirements for an effective surveillance system designed to support critical decision-making during future pandemics.</li>
                    
                    <li>It identifies the precise data elements required to inform public health guidance and policies, as well as to accurately calibrate inputs and outputs of transmission-dynamic models.</li>
                    
                    <li>Data needs are explicitly defined to cater to the diverse decision-making processes of state, territorial, local, and tribal health authorities.</li>
                    
                    <li>The analysis draws insights from both U.S. and international jurisdictions regarding the utility and value of specific types of surveillance data.</li>
                    
                    <li>Actionable steps are outlined to ensure the consistent availability of the necessary surveillance data for a robust public health response.</li>
                    
                    <li>A key consideration of the proposed surveillance enhancements is their potential contribution to improving health equity across populations.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The paper employs a qualitative, analytical approach, synthesizing lessons learned from the COVID-19 pandemic experience in the U.S. and globally. It involves defining system requirements, identifying specific data elements, and conceptualizing actionable steps for surveillance system improvement, rather than conducting empirical research or data collection.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary findings are the detailed articulation of surveillance needs and specific data requirements essential for an effective pandemic response system. These include defining the range of decisions requiring surveillance data, identifying necessary data elements for informing decisions and calibrating transmission models, and specifying data types relevant to different levels of health authorities, all informed by critical lessons from COVID-19.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>Improved and standardized surveillance data will lead to more timely and accurate clinical guidance, better resource allocation (e.g., hospital capacity, therapeutics, vaccines), and more effective public health interventions. This will ultimately result in better patient management, reduced disease transmission, and decreased morbidity and mortality during infectious disease outbreaks.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the analysis presented in the paper itself. It rather focuses on addressing the limitations of existing infectious disease surveillance systems, which were highlighted by the COVID-19 pandemic.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future directions involve the concrete implementation of the defined actions to ensure the availability of critical surveillance data. This includes developing and integrating infrastructure for comprehensive data collection, analysis, and dissemination, with a sustained focus on supporting informed public health decision-making and advancing health equity.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Public Health</span>
                    
                    <span class="tag">Infectious Diseases</span>
                    
                    <span class="tag">Epidemiology</span>
                    
                    <span class="tag">Health Policy</span>
                    
                    <span class="tag">Preventive Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Infectious Disease Surveillance</span>
                    
                    <span class="tag tag-keyword">COVID-19</span>
                    
                    <span class="tag tag-keyword">Public Health</span>
                    
                    <span class="tag tag-keyword">Pandemic Preparedness</span>
                    
                    <span class="tag tag-keyword">Data Requirements</span>
                    
                    <span class="tag tag-keyword">Transmission Modeling</span>
                    
                    <span class="tag tag-keyword">Health Equity</span>
                    
                    <span class="tag tag-keyword">Decision Support</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The COVID-19 pandemic has highlighted the need to upgrade systems for infectious disease surveillance and forecasting and modeling of the spread of infection, both of which inform evidence-based public health guidance and policies. Here, we discuss requirements for an effective surveillance system to support decision making during a pandemic, drawing on the lessons of COVID-19 in the U.S., while looking to jurisdictions in the U.S. and beyond to learn lessons about the value of specific data types. In this report, we define the range of decisions for which surveillance data are required, the data elements needed to inform these decisions and to calibrate inputs and outputs of transmission-dynamic models, and the types of data needed to inform decisions by state, territorial, local, and tribal health authorities. We define actions needed to ensure that such data will be available and consider the contribution of such efforts to improving health equity.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>